These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32683301)

  • 41. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
    Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
    Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
    Yuan X; He Y; Luo C; Wang W
    Invest New Drugs; 2022 Apr; 40(2):232-244. PubMed ID: 34633577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells.
    Wang K; Ding Y; Liu Y; Ma M; Wang J; Kou Z; Liu S; Jiang B; Hou S
    J Cell Mol Med; 2024 Apr; 28(7):e18165. PubMed ID: 38494845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
    Tang F; Lu Z; He C; Zhang H; Wu W; He Z
    BMC Cancer; 2021 May; 21(1):638. PubMed ID: 34051738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma.
    Shi N; Chen S; Wang D; Wu T; Zhang N; Chen M; Ding X
    Sci Rep; 2024 Aug; 14(1):18254. PubMed ID: 39107475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
    Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
    Liu F; Wang P; Sun W; Jiang Y; Gong Q
    Front Immunol; 2022; 13():874056. PubMed ID: 35734169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
    Zhang H; Liu Y; Wang B; Wang C
    BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients.
    Meng Y; Cai K; Zhao J; Huang K; Ma X; Song J; Liu Y
    J Immunol Res; 2021; 2021():5598627. PubMed ID: 33791390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
    Bao W; Han Q; Guan X; Wang Z; Gu M
    Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy.
    Bai D; Feng H; Yang J; Yin A; Qian A; Sugiyama H
    Cancer Sci; 2021 Jun; 112(6):2126-2139. PubMed ID: 33735492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
    Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
    Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
    Theodros D; Murter BM; Sidhom JW; Nirschl TR; Clark DJ; Chen L; Tam AJ; Blosser RL; Schwen ZR; Johnson MH; Pierorazio PM; Zhang H; Ganguly S; Pardoll DM; Zarif JC
    Mol Cell Proteomics; 2020 Nov; 19(11):1850-1859. PubMed ID: 32737216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
    Zhao J; Pan X; Wang Z; Chen Y; Liu D; Shen Y; Wei X; Xu C; Zhang X; Hu X; Chen J; Zhao J; Tang B; Sun G; Shen P; Liu Z; Zeng H; Liang J
    Eur J Med Res; 2024 Jul; 29(1):378. PubMed ID: 39033192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrative analysis of TRPV family to prognosis and immune infiltration in renal clear cell carcinoma.
    Gong Z; Xie J; Chen L; Tang Q; Hu Y; Xu A; Wang Z
    Channels (Austin); 2022 Dec; 16(1):84-96. PubMed ID: 35389815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
    Zhou Q; Qi Y; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Xu L; Dai B; Guo J; Zhu Y; Zhang W; Xu J
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32371459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
    Fu Y; Piao C; Zhang Z; Zhu Y; Sun S; Bi J; Kong C; Ju M
    Urol Oncol; 2020 Sep; 38(9):740.e1-740.e9. PubMed ID: 32402768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.